| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Director | Common Stock | 73.7K | $567K | $7.70 | Jun 1, 2025 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | Director | Common Stock | 7K | $413K | $58.97 | Jun 18, 2025 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 12.3K | $193K | $15.74 | Jun 1, 2024 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 23.1K | $108K | $8.83 | Jun 1, 2025 | Direct |
| NEOGENOMICS INC | Director | Stock Option (Right to Buy) | 16.1K | $76.6K | $8.83 | Jun 1, 2025 | Direct |
| NEOGENOMICS INC | Director | Common Stock | 7K | $53.9K | $7.70 | Jun 1, 2025 | Lynn Tetrault Rollover IRA |
| RHYTHM PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 4.71K | $0 | $39.10 | Jun 24, 2025 | Direct |
| ALUMIS INC. | Director | Stock Option (Right to Buy) | 49.8K | Jul 30, 2025 | Direct | ||
| RHYTHM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 7.04K | Jun 24, 2025 | Direct | ||
| ACELYRIN, Inc. | Director | Director Stock Option (right to buy) | 0 | May 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | Jul 30, 2025 | 1 | $0 | 4 | Aug 1, 2025 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 24, 2025 | 2 | $0 | 4 | Jun 26, 2025 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 18, 2025 | 2 | $0 | 4 | Jun 23, 2025 | Director |
| NEO | NEOGENOMICS INC | Jun 1, 2025 | 4 | $0 | 4 | Jun 3, 2025 | Director |
| SLRN | ACELYRIN, Inc. | May 21, 2025 | 2 | $0 | 4 | May 23, 2025 | Director |
| ALMS | ALUMIS INC. | May 21, 2025 | 0 | $0 | 3 | May 23, 2025 | Director |
| NEO | NEOGENOMICS INC | May 9, 2025 | 1 | $57K | 4 | May 9, 2025 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Sep 9, 2024 | 10 | -$784K | 4 | Sep 11, 2024 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Aug 26, 2024 | 3 | -$133K | 4 | Aug 28, 2024 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Aug 12, 2024 | 4 | -$405K | 4 | Aug 14, 2024 | Director |
| NEO | NEOGENOMICS INC | Aug 10, 2024 | 2 | $0 | 4 | Aug 13, 2024 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 21, 2024 | 2 | $0 | 4 | Jun 25, 2024 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
| SLRN | ACELYRIN, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| NEO | NEOGENOMICS INC | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| NEO | NEOGENOMICS INC | Mar 4, 2024 | 1 | -$97.6K | 4 | Mar 6, 2024 | Director |
| SLRN | ACELYRIN, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Director |
| SLRN | ACELYRIN, Inc. | Dec 18, 2023 | 0 | $0 | 3 | Dec 20, 2023 | Director |
| NEO | NEOGENOMICS INC | Aug 10, 2023 | 2 | $0 | 4 | Aug 14, 2023 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 21, 2023 | 2 | $0 | 4 | Jun 23, 2023 | Director |
| NEO | NEOGENOMICS INC | May 22, 2023 | 2 | $17.5K | 4 | May 24, 2023 | Director |
| NEO | NEOGENOMICS INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| NEO | NEOGENOMICS INC | May 18, 2022 | 2 | $24.2K | 4 | May 20, 2022 | Director |
| NEO | NEOGENOMICS INC | Oct 11, 2021 | 2 | $0 | 4 | Oct 13, 2021 | Director |
| NEO | NEOGENOMICS INC | Jun 11, 2021 | 2 | $12.7K | 4 | Jun 14, 2021 | Director |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
| NEO | NEOGENOMICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |